A US ‐Based Multi‐Site Pilot to Screen Hepatitis B Surface Antigen‐Positive Patients for Hepatitis D
Journal of Viral Hepatitis · 2025
DOI: 10.1111/jvh.14043 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of Viral Hepatitis, 2025. Verfasst von Maggie Li und 13 weiteren Autor:innen. Beteiligte Einrichtung: Sinai Infectious Disease Center, Sinai Chicago, Chicago, Illinois, USA. Hauptthemen laut MEDLINE: Hepatitis B Surface Antigens, Hepatitis D, Hepatitis Delta Virus, Mass Screening. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Hepatitis D (HDV) is a severe infection with well‐recognised clinical ramifications that remains relatively neglected and underdiagnosed; consequently, the epidemiology of HDV is poorly characterised, both in the United States and globally. In 2022, a pilot project involving eight healthcare institutions was undertaken to ascertain the prevalence of HDV in healthcare institutions with an HBV seropositivity of at least 1%, describe the characteristics of patients testing positive for HDV, and evaluate diagnostic and laboratory processes of HDV screening. From August 2022 to April 2024, a total of 106,693 patients were tested for HBsAg, of whom 65,341 (61.2%) were female and 40,863 (38.3%) were male, with a mean age of 47 years. The overall HBsAg positivity rate was 1.04% ( n = 1112). Among the HBsAg+ samples, 645 (58.0%) underwent HDV Ab testing. The HDV Ab positivity rate was 0.81% ( n = 9), with 2 cases of HDV RNA positivity (0.18%). The incomplete testing reflects several challenges associated with screening for both HBV and HDV. Further research is necessary to better understand the epidemiology and burden of HDV in the United States and considerations for implementation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Sinai Infectious Disease Center, Sinai Chicago, Chicago, Illinois, USA.
- Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
- Hackensack University Medical Center, Hackensack Meridian Health, Hackensack, New Jersey, USA.
- Hackensack Meridian School of Medicine, Nutley, New Jersey, USA.
- NewYork-Presbyterian Queens/Columbia University, Flushing, New York, USA.
- Norton Healthcare, Louisville, Kentucky, USA.
ORCID-Profile: Maggie Li, Madhu Suryadevara
Zitieren
APA
Li, M., Hunt, B., Balani, B., Ogedegbe, C., Gordon, P., Hayden, J., Glick, N., Chang, A., Wang, S., Caponi, M., Yarber-Cambron, L., Bhat, S., Ward, T., & Suryadevara, M. (2025). A US ‐Based Multi‐Site Pilot to Screen Hepatitis B Surface Antigen‐Positive Patients for Hepatitis D. Journal of Viral Hepatitis. https://doi.org/10.1111/jvh.14043
Vancouver
Li M, Hunt B, Balani B, Ogedegbe C, Gordon P, Hayden J, et al. A US ‐Based Multi‐Site Pilot to Screen Hepatitis B Surface Antigen‐Positive Patients for Hepatitis D. Journal of Viral Hepatitis. 2025. doi:10.1111/jvh.14043
BibTeX
@article{Li2025,
author = {Li, Maggie and Hunt, Bijou and Balani, Bindu and Ogedegbe, Chinwe and Gordon, Peter and Hayden, Joshua and Glick, Nancy and Chang, Anita and Wang, Su and Caponi, Mitchell and Yarber-Cambron, Lisa and Bhat, Sandeep and Ward, Tyshea and Suryadevara, Madhu},
title = {A US ‐Based Multi‐Site Pilot to Screen Hepatitis B Surface Antigen‐Positive Patients for Hepatitis D},
journal = {Journal of Viral Hepatitis},
year = {2025},
doi = {10.1111/jvh.14043}
}
EUVIMED